Research and Study at the University of Excellence in Bonn

We eat too much meat in Germany and this not only has a negative impact on health but is also damaging for the environment and climate. Cafeteria owners are increasingly open to the idea of serving smaller portions of meat – especially for cost reasons. But how do you encourage their customers to choose smaller portions of meat? Researchers at the University of Bonn have been investigating this question at a cafeteria in a rehabilitation clinic. The desired effect was the biggest when the team at the cafeteria simply served smaller portions of meat and only topped them up when this was requested by customers. This approach was also largely accepted by patrons. The results have now been published in the journal “Environment and Behavior.”

Anton Bovier, professor at the Institute for Applied Mathematics at the University of Bonn and member of the Cluster of Excellence Hausdorff Center for Mathematics (HCM), has been elected as fellow of the European Academy of Sciences (EurASc). 

Researchers at the University of Bonn and the University of Cambridge have identified an important control circuit involved in the eating process. The study has revealed that fly larvae have special sensors, or receptors, in their esophagus that are triggered as soon as the animal swallows something. If the larva has swallowed food, they tell the brain to release serotonin. This messenger substance – which is often also referred to as the feel-good hormone – ensures that the larva continues to eat. The researchers assume that humans also have a very similar control circuit. The results were recently published in the journal “Current Biology.”

An unprecedented program is to be rolled out to deal with future pandemics: Researchers from the Universities of Melbourne and Bonn and University Hospital of Bonn are teaming up with a billionaire backer to develop new therapeutics and strengthen natural immune response. The Cumming Global Centre and the University of Bonn have today announced the creation of the Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program. Initial program funding of €6 million may potentially be increased to up to €40 million. Philanthropic billionaire Geoff Cumming is putting up a large part of this funding.